Industrial Biotechnology Commercialization Handbook PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Industrial Biotechnology Commercialization Handbook PDF full book. Access full book title Industrial Biotechnology Commercialization Handbook by Mark Warner Pe. Download full books in PDF and EPUB format.
Author: Mark Warner Pe
Publisher:
ISBN: 9781079229950
Category :
Languages : en
Pages : 106
Get Book Here
Book Description
How much will it cost, how long will it take and is the technology ready to commercialize? These are the three most common questions received from founders, investors and employees looking to commercialize novel biotechnologies. This handbook provides industry insight and practical explanations of the commercialization process, including common pitfalls to avoid on the way to success. Mark Warner is a registered professional chemical engineer who started his career at Monsanto Chemical, turning waste pulp and paper byproducts into foods and chemicals. After spending a decade in large engineering firms, he joined an early-stage renewable energy venture and has not looked back. Mark leveraged the initial biofuels experience to hold executive level positions with industry names such as Impossible Foods, Solazyme, Harris Group and Imperium Renewables. Warner Advisors LLC was founded in 2015 with a mission of assisting early-stage biotechnology companies in commercializing their technologies. To date, Mark has consulted for over 40 industrial biotechnology ventures and is recognized as an expert in biotechnology commercialization.
Author: Mark Warner Pe
Publisher:
ISBN: 9781079229950
Category :
Languages : en
Pages : 106
Get Book Here
Book Description
How much will it cost, how long will it take and is the technology ready to commercialize? These are the three most common questions received from founders, investors and employees looking to commercialize novel biotechnologies. This handbook provides industry insight and practical explanations of the commercialization process, including common pitfalls to avoid on the way to success. Mark Warner is a registered professional chemical engineer who started his career at Monsanto Chemical, turning waste pulp and paper byproducts into foods and chemicals. After spending a decade in large engineering firms, he joined an early-stage renewable energy venture and has not looked back. Mark leveraged the initial biofuels experience to hold executive level positions with industry names such as Impossible Foods, Solazyme, Harris Group and Imperium Renewables. Warner Advisors LLC was founded in 2015 with a mission of assisting early-stage biotechnology companies in commercializing their technologies. To date, Mark has consulted for over 40 industrial biotechnology ventures and is recognized as an expert in biotechnology commercialization.
Author:
Publisher:
ISBN:
Category : Biotechnology industries
Languages : en
Pages : 28
Get Book Here
Book Description
Author: Craig Shimasaki
Publisher: Academic Press
ISBN: 0124047475
Category : Medical
Languages : en
Pages : 489
Get Book Here
Book Description
As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a 'how-to' for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. - Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars - Case studies are interspersed throughout each chapter to support key concepts and best practices. - Enhanced by use of numerous detailed graphics, tables and flow charts
Author: Fred Mermelstein
Publisher:
ISBN: 9781942911371
Category : Biotechnology
Languages : en
Pages : 1026
Get Book Here
Book Description
Author: Gary P. Pisano
Publisher: Harvard Business Press
ISBN: 9781591398400
Category : Business & Economics
Languages : en
Pages : 278
Get Book Here
Book Description
Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.
Author: Krishna R. Dronamraju
Publisher: World Scientific
ISBN: 9812775013
Category : Business & Economics
Languages : en
Pages : 485
Get Book Here
Book Description
The principal message of this book is that thermodynamics and statistical mechanics will benefit from replacing the unfortunate, misleading and mysterious term "entropy" with a more familiar, meaningful and appropriate term such as information, missing information or uncertainty. This replacement would facilitate the interpretation of the "driving force" of many processes in terms of informational changes and dispel the mystery that has always enshrouded entropy. It has been 140 years since Clausius coined the term "entropy"; almost 50 years since Shannon developed the mathematical theory of "information"--Subsequently renamed "entropy." In this book, the author advocates replacing "entropy" by "information," a term that has become widely used in many branches of science. The author also takes a new and bold approach to thermodynamics and statistical mechanics. Information is used not only as a tool for predicting distributions but as the fundamental cornerstone concept of thermodynamics, held until now by the term "entropy." The topics covered include the fundamentals of probability and information theory; the general concept of information as well as the particular concept of information as applied in thermodynamics; the re-derivation of the Sackur-Tetrode equation for the entropy of an ideal gas from purely informational arguments; the fundamental formalism of statistical mechanics; and many examples of simple processes the "driving force" for which is analyzed in terms of information.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309452058
Category : Science
Languages : en
Pages : 231
Get Book Here
Book Description
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
Author: Yali Friedman
Publisher: Thinkbiotech
ISBN: 9780973467635
Category : Business & Economics
Languages : en
Pages : 306
Get Book Here
Book Description
Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry: * Cultivate a career in biotechnology, with or without an MBA or Ph.D. * Fund and assemble a company * Manage research and development, alliances, and funding * Understand the diverse factors defining the biotechnology industry * Invest intelligently in biotechnology This second edition significantly expands upon the foundation laid by the first, updating recent developments and adding significantly more case studies, informative figures and tables.
Author: Shreefal S. Mehta
Publisher: Cambridge University Press
ISBN: 110739421X
Category : Technology & Engineering
Languages : en
Pages : 449
Get Book Here
Book Description
Successful product design and development requires the ability to take a concept and translate the technology into useful, patentable, commercial products. This book guides the reader through the practical aspects of the commercialization process of drug, diagnostic and device biomedical technology including market analysis, product development, intellectual property and regulatory constraints. Key issues are highlighted at each stage in the process, and case studies are used to provide practical examples. The book will provide a sound road map for those involved in the biotechnology industry to effectively plan the commercialization of profitable regulated medical products. It will also be suitable for a capstone design course in engineering and biotechnology, providing the student with the business acumen skills involved in product development.
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309316553
Category : Science
Languages : en
Pages : 158
Get Book Here
Book Description
The tremendous progress in biology over the last half century - from Watson and Crick's elucidation of the structure of DNA to today's astonishing, rapid progress in the field of synthetic biology - has positioned us for significant innovation in chemical production. New bio-based chemicals, improved public health through improved drugs and diagnostics, and biofuels that reduce our dependency on oil are all results of research and innovation in the biological sciences. In the past decade, we have witnessed major advances made possible by biotechnology in areas such as rapid, low-cost DNA sequencing, metabolic engineering, and high-throughput screening. The manufacturing of chemicals using biological synthesis and engineering could expand even faster. A proactive strategy - implemented through the development of a technical roadmap similar to those that enabled sustained growth in the semiconductor industry and our explorations of space - is needed if we are to realize the widespread benefits of accelerating the industrialization of biology. Industrialization of Biology presents such a roadmap to achieve key technical milestones for chemical manufacturing through biological routes. This report examines the technical, economic, and societal factors that limit the adoption of bioprocessing in the chemical industry today and which, if surmounted, would markedly accelerate the advanced manufacturing of chemicals via industrial biotechnology. Working at the interface of synthetic chemistry, metabolic engineering, molecular biology, and synthetic biology, Industrialization of Biology identifies key technical goals for next-generation chemical manufacturing, then identifies the gaps in knowledge, tools, techniques, and systems required to meet those goals, and targets and timelines for achieving them. This report also considers the skills necessary to accomplish the roadmap goals, and what training opportunities are required to produce the cadre of skilled scientists and engineers needed.
